<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02357303</url>
  </required_header>
  <id_info>
    <org_study_id>PortugueseOIC 001</org_study_id>
    <nct_id>NCT02357303</nct_id>
  </id_info>
  <brief_title>Simethicone and N-acetylcysteine in Upper Endoscopy - Prospective Double-blinded Randomized Controlled Trial</brief_title>
  <official_title>Premedication With Simethicone and N-acetylcysteine in Improving Mucosal Visibility During Upper Endoscopy - a Prospective Double-blinded Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Portuguese Oncology Institute, Coimbra</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Portuguese Oncology Institute, Coimbra</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The upper endoscopy is one of the most common methods for the diagnosis and treatment of
      upper gastrointestinal (GI) tract diseases and provides a unique opportunity to identify
      early neoplastic lesions.

      Before an upper endoscopy it is required a 6 hour fasting period[1]. However, even with this
      fasting period, sometimes the mucosal visualization, especially in the stomach, is impaired
      by the presence of foam, bubbles or gastric mucus.

      To improve visualization of the gastric mucosa, it is possible to administrate an oral
      solution of defoaming agents such as Simethicone and mucolytic agents like Pronase or
      N-Acetylcysteine previously to the procedure.

      The aim of this project is to determine if the use of premedication with simethicone, alone
      or in association with N-Acetylcysteine, improves mucosal visualization during an upper GI
      endoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      a. Study type: prospective, randomized, double-blinded, placebo-controlled trial: i.
      Prospective inclusion of patients; ii. Randomization by computer generated tables; iii.
      Allocation concealment by sealed, opaque envelopes; iv. Double-blinded - nurse instructed not
      to reveal treatment; patient and doctor unaware of treatment;

      b. Patient selection: consecutive series of patients scheduled for upper gastrointestinal
      endoscopy; Exclusion criteria - sedation, previous total gastrectomy, known neoplasia or
      stenosis, allergies to simethicone or N-acetylcysteine, therapeutic or urgent procedures;

      c. Sample size: 270 (3 groups of 90 patients): to improve &quot;excellent&quot; preparations from 20%
      (value from our own database) to 40% and assuming a normal distribution and a power of 80%
      (α=0.05), the calculated sample size of each of the 3 groups was 82; allowing for a 10%
      dropout rate, the sample size is 90 (270 patients overall); Groups: Group A - 100mL of water
      (placebo); Group B - 100mL of water plus 100mg Simethicone; Group C - 100mL of water plus
      100mg Simethicone plus 600mg N-acetylcysteine;

      d. Data collection methods: form sheet filled by nurses (appendix 1) and endoscopist
      (appendix 2);

      e. Analysed variables: patients characteristics (age, gender), indication for endoscopy, time
      from administration to procedure, score of mucosal visualization, side effects of medication;

      f. Statistical analysis: chi-square test.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score of mucosal visualization</measure>
    <time_frame>1 day (During endoscopy)</time_frame>
    <description>Evaluation of the visibility of gastric mucosa during upper endoscopy using a scale (excelent, adequadate or inadequate) for esophagus, stomach and duodenum</description>
  </primary_outcome>
  <other_outcome>
    <measure>Drug side effects</measure>
    <time_frame>1 day (During endoscopy)</time_frame>
    <description>Evaluation of the drug side effects during upper endoscopy (report of any allergic reaction)</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Gastric Mucosal Lesion</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Group A - 100mL of water by mouth, 15 to 30 minutes before endoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Simethicone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group B - 100mL of water plus 100mg Simethicone by mouth, 15 to 30 minutes before endoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Simethicone plus N-acetylcysteine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group C - 100mL of water plus 100mg Simethicone plus 600mg N-acetylcysteine by mouth, 15 to 30 minutes before endoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Simethicone</intervention_name>
    <description>100mL of water plus 100mg Simethicone by mouth, 15 to 30 minutes before endoscopy</description>
    <arm_group_label>Simethicone</arm_group_label>
    <other_name>Aero-OM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetylcysteine</intervention_name>
    <description>100mL of water plus 100mg Simethicone plus 600mg N-acetylcysteine by mouth, 15 to 30 minutes before endoscopy</description>
    <arm_group_label>Simethicone plus N-acetylcysteine</arm_group_label>
    <other_name>Fluimucil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>100mL of water</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  consecutive series of patients scheduled for upper gastrointestinal endoscopy

          -  signed informed consent

        Exclusion Criteria:

          -  sedation

          -  previous total gastrectomy

          -  known neoplasia or stenosis

          -  therapeutic or urgent procedures

          -  allergies to simethicone or N-acetylcysteine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luís Elvas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gastroenterology Department, Portuguese Oncology Institute - Coimbra</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Portuguese Oncology Institute - Coimbra</name>
      <address>
        <city>Coimbra</city>
        <zip>3001-651</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <reference>
    <citation>Faigel DO, Eisen GM, Baron TH, Dominitz JA, Goldstein JL, Hirota WK, Jacobson BC, Johanson JF, Leighton JA, Mallery JS, Raddawi HM, Vargo JJ 2nd, Waring JP, Fanelli RD, Wheeler-Harbough J; Standards of Practice Committee. American Society for Gastrointestinal Endoscopy. Preparation of patients for GI endoscopy. Gastrointest Endosc. 2003 Apr;57(4):446-50.</citation>
    <PMID>12665751</PMID>
  </reference>
  <reference>
    <citation>Asl SM, Sivandzadeh GR. Efficacy of premedication with activated Dimethicone or N-acetylcysteine in improving visibility during upper endoscopy. World J Gastroenterol. 2011 Oct 7;17(37):4213-7. doi: 10.3748/wjg.v17.i37.4213.</citation>
    <PMID>22072853</PMID>
  </reference>
  <reference>
    <citation>Chen MJ, Wang HY, Chang CW, Hu KC, Hung CY, Chen CJ, Shih SC. The add-on N-acetylcysteine is more effective than dimethicone alone to eliminate mucus during narrow-band imaging endoscopy: a double-blind, randomized controlled trial. Scand J Gastroenterol. 2013 Feb;48(2):241-5. doi: 10.3109/00365521.2012.749509. Epub 2012 Dec 27.</citation>
    <PMID>23268593</PMID>
  </reference>
  <reference>
    <citation>Bhandari P, Green S, Hamanaka H, Nakajima T, Matsuda T, Saito Y, Oda I, Gotoda T. Use of Gascon and Pronase either as a pre-endoscopic drink or as targeted endoscopic flushes to improve visibility during gastroscopy: a prospective, randomized, controlled, blinded trial. Scand J Gastroenterol. 2010 Mar;45(3):357-61. doi: 10.3109/00365520903483643.</citation>
    <PMID>20148732</PMID>
  </reference>
  <reference>
    <citation>Ahsan M, Babaei L, Gholamrezaei A, Emami MH. Simethicone for the Preparation before Esophagogastroduodenoscopy. Diagn Ther Endosc. 2011;2011:484532. doi: 10.1155/2011/484532. Epub 2011 Aug 4.</citation>
    <PMID>21826120</PMID>
  </reference>
  <reference>
    <citation>Bertoni G, Gumina C, Conigliaro R, Ricci E, Staffetti J, Mortilla MG, Pacchione D. Randomized placebo-controlled trial of oral liquid simethicone prior to upper gastrointestinal endoscopy. Endoscopy. 1992 May;24(4):268-70.</citation>
    <PMID>1612040</PMID>
  </reference>
  <reference>
    <citation>Keeratichananont S, Sobhonslidsuk A, Kitiyakara T, Achalanan N, Soonthornpun S. The role of liquid simethicone in enhancing endoscopic visibility prior to esophagogastroduodenoscopy (EGD): A prospective, randomized, double-blinded, placebo-controlled trial. J Med Assoc Thai. 2010 Aug;93(8):892-7.</citation>
    <PMID>20718163</PMID>
  </reference>
  <reference>
    <citation>Kuo CH, Sheu BS, Kao AW, Wu CH, Chuang CH. A defoaming agent should be used with pronase premedication to improve visibility in upper gastrointestinal endoscopy. Endoscopy. 2002 Jul;34(7):531-4.</citation>
    <PMID>12170403</PMID>
  </reference>
  <reference>
    <citation>Lee GJ, Park SJ, Kim SJ, Kim HH, Park MI, Moon W. Effectiveness of Premedication with Pronase for Visualization of the Mucosa during Endoscopy: A Randomized, Controlled Trial. Clin Endosc. 2012 Jun;45(2):161-4. doi: 10.5946/ce.2012.45.2.161. Epub 2012 Jun 30.</citation>
    <PMID>22866258</PMID>
  </reference>
  <reference>
    <citation>Fujii T, Iishi H, Tatsuta M, Hirasawa R, Uedo N, Hifumi K, Omori M. Effectiveness of premedication with pronase for improving visibility during gastroendoscopy: a randomized controlled trial. Gastrointest Endosc. 1998 May;47(5):382-7.</citation>
    <PMID>9609431</PMID>
  </reference>
  <reference>
    <citation>Zala G, Flury R, Wüst J, Meyenberger C, Ammann R, Wirth HP. [Omeprazole/amoxicillin: improved eradication of Helicobacter pylori in smokers because of N-acetylcysteine]. Schweiz Med Wochenschr. 1994 Aug 9;124(31-32):1391-7. German.</citation>
    <PMID>8091167</PMID>
  </reference>
  <reference>
    <citation>Chang CC, Chen SH, Lin CP, Hsieh CR, Lou HY, Suk FM, Pan S, Wu MS, Chen JN, Chen YF. Premedication with pronase or N-acetylcysteine improves visibility during gastroendoscopy: an endoscopist-blinded, prospective, randomized study. World J Gastroenterol. 2007 Jan 21;13(3):444-7.</citation>
    <PMID>17230616</PMID>
  </reference>
  <reference>
    <citation>Chang WK, Yeh MK, Hsu HC, Chen HW, Hu MK. Efficacy of simethicone and N-acetylcysteine as premedication in improving visibility during upper endoscopy. J Gastroenterol Hepatol. 2014 Apr;29(4):769-74. doi: 10.1111/jgh.12487.</citation>
    <PMID>24325147</PMID>
  </reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 29, 2015</study_first_submitted>
  <study_first_submitted_qc>February 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2015</study_first_posted>
  <last_update_submitted>January 7, 2016</last_update_submitted>
  <last_update_submitted_qc>January 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Portuguese Oncology Institute, Coimbra</investigator_affiliation>
    <investigator_full_name>Luís André Caio Elvas</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Randomized controlled trial</keyword>
  <keyword>Endoscopy</keyword>
  <keyword>Gastric mucosa</keyword>
  <keyword>Simethicone</keyword>
  <keyword>Acetylcysteine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetylcysteine</mesh_term>
    <mesh_term>N-monoacetylcystine</mesh_term>
    <mesh_term>Simethicone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

